#iwAL25
🩸🎥 Approaching TP53-mutated AML: current challenges, ongoing research & novel therapeutic strategies.

Don't miss this insightful roundtable discussion from #iwAL25 with leading experts Eunice Wang, David Sallman, Gabriel Mannis, & Andrew Wei.

Watch now: 👉 buff.ly/VJJUbmz

#AMLsm #Leusm #Leukemia
November 11, 2025 at 10:01 AM
#iwAL25 | John DiPersio comments on the challenges of treating T-cell malignancies with bispecific antibody therapy, and shares insights into the development of WU-CART-007, an anti-CD7 allogeneic CAR T-cell product:

🎥 buff.ly/s2zXiCa

#ALLsm #Leusm #ImmunoOnc #HemOnc #BloodSky #HemeSky #MedSky
October 29, 2025 at 5:42 PM
🎥 Sanam Loghavi and Guillermo Montalban-Bravo of @mdanderson.bsky.social sat down at #iwAL25 to share insights into the diagnosis and classification of CMML, commenting on how the current approach to this could be refined:

👉 buff.ly/5ZwQxnP 👈

#Leusm #HemOnc #RareDisease #MDSsm #BloodSky #HemeSky
October 9, 2025 at 8:29 AM
In an interview from #iwAL25, Tara Lin discusses the possibility of tailoring treatment for secondary AML dependent on mutational profile, highlighting the heterogeneity of this disease.

Watch here:

👉 buff.ly/HbJTfmF 👈

#AMLsm #Leusm #Leukemia #HemOnc #BloodSky
November 2, 2025 at 4:01 PM
Want to hear highlights from #iwAL25?🩸

Check out our fantastic roundtable discussion with leading experts Harry Erba, Thomas Cluzeau, Marina Konopleva, & Aditi Shastri by clicking here:

👉 buff.ly/wtheBJa 👈

#AMLsm #Leusm #Leukemia #HemOnc #BloodSky #HemeSky #MedSky
October 21, 2025 at 1:04 PM
Want to hear about the evolving role of menin inhibitors in AML?🩸

Don't miss our roundtable discussion on this topic from #iwAL25, featuring leading experts Naval Daver, @leukdocjz.bsky.social, Eytan Stein, & Amir Fathi.

Watch here: 👉 buff.ly/iaEfMsV

#AMLsm #Leusm #HemOnc #BloodSky #HemeSky
October 15, 2025 at 5:00 PM
#iwAL25 | Charlie Craddock answers YOUR transplantation questions in a special Ask the Expert session!

Watch here:

👉 buff.ly/TRqoc4q%F0%9...

#HemOnc #ImmunoOnc #AMLsm #BMTsm #Leusm #BloodSky #HemeSky #MedSky
October 11, 2025 at 1:03 PM
At #iwAL25, leading experts Mark Levis, Eunice Wang, and Sanam Loghavi participated in a thought-provoking debate about the value and utility of MRD in the management of adults with newly diagnosed AML.🩸

Watch it here: 👉 buff.ly/XfMfsmQ

#AMLsm #Leusm #MRD #HemOnc #BloodSky #HemeSky #MedSky
October 5, 2025 at 2:01 PM